By John Q. Hosedrinker 
A watchdog group, Private Equity Stakeholder Project (PESP), has released a report highlighting over 500 joint ventures between private equity firms and non-profit healthcare providers. PESP asserts that these arrangements pose significant risks to patients, payers, and employees, potentially leading to profit extraction and a decline in care quality. The report details how these partnerships operate and includes case studies suggesting private equity investments can alter the nature of non-profit healthcare, prompting calls for increased government oversight to ensure these ventures uphold their charitable missions.
Read the original article here
A growing presence of private equity in the U.S. healthcare system is raising serious concerns, with a watchdog group issuing warnings about potential risks to patients. This trend isn’t entirely new; the same forces have already significantly altered industries like dentistry and veterinary medicine, and the worry is that the same “enshittification” process is now accelerating within our medical facilities. It’s a stark reminder of how the pursuit of profit can often overshadow patient well-being, a scenario that seems particularly alarming when applied to something as essential as healthcare.
The sheer scale of private equity investment in healthcare is staggering. Researchers have indicated that over the past decade, these funds have poured more than a trillion dollars into debt-financed healthcare deals. This significant influx of capital, often coupled with short investment horizons, is creating a fundamental tension with the core principles of medical practice. Lawmakers and academics alike are scrutinizing these practices, questioning whether a model driven by quick financial returns is compatible with the long-term, patient-centered approach that healthcare demands.
One striking example of the potential fallout comes from Steward Health. This once-prominent for-profit hospital system, the largest in the U.S. in 2017, found itself in bankruptcy court just seven years later, burdened by a debt of $9 billion. Reports suggest that hundreds of millions of dollars were extracted for investors, including the CEO, leaving the company in dire straits. This financial distress reportedly led to the neglect of facilities, with buildings falling into disrepair and a lack of essential medical supplies, ultimately resulting in the closure of hospitals and leaving communities without crucial healthcare access.
Beyond the direct impact on hospital systems, there’s a growing concern about joint ventures between private equity firms and non-profit healthcare providers. A watchdog group is actively advocating for increased government oversight of these arrangements, highlighting that they could introduce significant “risks” not only to patients but also to payers and employees. This suggests a complex web of financial maneuvers that may not always prioritize the best interests of those directly involved in receiving or providing care.
The core of the issue often boils down to the inherent conflict between the drive for profit and the fundamental mission of healthcare. When the primary objective shifts from healing and well-being to maximizing returns for shareholders, the quality and accessibility of care can inevitably suffer. This sentiment is echoed by many who observe that as soon as profit becomes the paramount concern in hospitals and clinics, it inevitably takes precedence over patient needs.
The potential consequences are far-reaching, extending even to specialized fields like mental health. Companies in this sector, often backed by private equity and insurance interests, have begun consolidating services. While they may initially offer appealing packages to clinicians, promising easier administrative processes and advertising support, the underlying model can lead to a devaluation of services. Clinicians may find themselves treated as interchangeable cogs, with reduced payouts and deteriorating working conditions, mirroring the experiences of others in less critical industries.
This shift can create a domino effect. As these venture capital-backed entities gain market share, they can stifle independent practitioners and smaller organizations that lack the resources for extensive advertising. Insurance companies, meanwhile, may become slower to update rates or even reduce reimbursements, creating further financial pressure. The ultimate outcome can be a reduced willingness for skilled professionals to enter these fields, leading to further under-servicing of populations in need, particularly in areas that are already underserved.
The concerns are amplified by the fact that private equity’s modus operandi often involves loading acquired companies with significant debt. This debt-fueled buying and short-term focus can lead to the stripping of assets and the eventual abandonment of a “hollowed-out shell.” When this business model is applied to essential infrastructure like healthcare, the implications are dire, as patients and medical staff bear the brunt of cost-cutting measures, rushed appointments, and inflated charges.
Some express a sense of resignation, suggesting that the system is so fundamentally flawed that “at least it wasn’t socialism” will be the epitaph for healthcare in America. There’s a cynical observation that this model of prioritizing profit above all else could eventually harm everyone, including the wealthy, either through societal breakdown or through their own sophisticated systems failing when true crises emerge.
The question arises: is there any instance where private equity has demonstrably improved things for ordinary people, not just for investors? The argument is that their business model is intrinsically at odds with actual medicine. The acquisition of independent clinics or nursing homes, followed by debt loading and asset stripping, leaves behind a system designed for quick cash extraction rather than sustained, quality care. This transforms healthcare visits into experiences that feel more akin to negotiating a transaction at a car dealership, where the focus is on squeezing every last penny, leaving patients and staff to suffer the consequences.
There’s a palpable fear that critical survival infrastructure is being handed over to entities primarily driven by a relentless pursuit of a 20% return for their investors. This necessitates cuts to staff, rushed patient interactions, and an increase in charges for every service. When healthcare is treated like a speculative investment, the human cost is immense, and the potential for neglect and denial of care becomes a significant risk.
Looking at the broader picture, the influence of private equity in healthcare is seen by some as a symptom of a larger systemic issue, where capitalism itself is at odds with the fundamental human need for medical treatment. Since illness is not something one chooses, the argument goes, pooling resources through a public healthcare system is the only ethical solution to ensure everyone receives the care they require. This perspective suggests that the current trajectory, driven by private equity, is pushing towards a dystopian future where access to care is dictated by financial capacity, rather than medical necessity. The irony of having to seek affordable care in other countries, like Mexico, is not lost on those witnessing this transformation. This is often described as a manifestation of “disaster capitalism,” where opportunities for profit are exploited during times of crisis or systemic vulnerability.